Valuation: Cogstate Limited

Market Cap 46Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3.02TCr 307.5Cr 119.48Cr 1.48TCr 118.62Cr 116.02Cr 5.14TCr P/E 2026 *
27.4x
P/E 2027 * 20.1x
Enterprise Value 40Cr 28Cr 24Cr 22Cr 21Cr 39Cr 2.65TCr 269.03Cr 104.53Cr 1.29TCr 103.78Cr 101.51Cr 4.5TCr EV / Sales 2026 *
4.6x
EV / Sales 2027 * 3.76x
Free-Float
54.16%
Yield 2026 *
1.21%
Yield 2027 * 1.52%

Last Transcript: Cogstate Limited

1 day+7.06%
1 week+6.27%
Current month+5.49%
1 month+11.20%
3 months+29.15%
6 months+32.11%
Current year+27.43%
1 week 2.57
Extreme 2.57
3
1 month 2.57
Extreme 2.57
3
Current year 2.01
Extreme 2.01
3
1 year 1.55
Extreme 1.55
3
3 years 0.8
Extreme 0.795
3
5 years 0.8
Extreme 0.795
3
10 years 0.16
Extreme 0.155
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap.
20/05Buy

Director

430 0.0003%
20/05Buy

Director

3,600 0.0021%
15/04
Myer & Myer Pty Ltd.
BuyCompany 99,74,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+7.06%+6.27%+70.41%+90.73% 32Cr
+0.24%+1.81%+2.17%+8.74% 4.94TCr
-0.36%+1.21%+420.77%+619.10% 4.03TCr
-2.13%+0.29%+23.91%-6.01% 3.4TCr
-2.29%+3.83%+23.48%+59.26% 3.36TCr
-0.79%+1.32%+5.78%+36.42% 2.68TCr
+3.82%+3.51% - - 1.72TCr
-2.62%-2.13%+64.96%+125.87% 1.52TCr
-2.17%+6.65%+104.31%+102.15% 1.4TCr
-0.51%-3.50%+11.76%+17.18% 1.34TCr
Average +0.03%+1.33%+80.84%+117.05% 2.44TCr
Weighted average by Cap. -0.74%+1.54%+94.54%+139.94%

Financials

2026 *2027 *
Net sales 8.69Cr 6.01Cr 5.27Cr 4.87Cr 4.5Cr 8.52Cr 575.47Cr 59Cr 23Cr 281.61Cr 23Cr 22Cr 977.59Cr 10Cr 7.07Cr 6.2Cr 5.72Cr 5.29Cr 10Cr 676.8Cr 69Cr 27Cr 331.2Cr 27Cr 26Cr 1.15TCr
Net income 1.69Cr 1.17Cr 1.02Cr 94.59L 87.41L 1.66Cr 111.85Cr 11Cr 4.42Cr 55Cr 4.39Cr 4.29Cr 190.01Cr 2.29Cr 1.58Cr 1.39Cr 1.28Cr 1.19Cr 2.25Cr 151.72Cr 15Cr 5.99Cr 74Cr 5.95Cr 5.82Cr 257.74Cr
Net Debt -5.72Cr -3.95Cr -3.47Cr -3.2Cr -2.96Cr -5.6Cr -378.39Cr -38Cr -15Cr -185.17Cr -15Cr -15Cr -642.81Cr -7.23Cr -5Cr -4.38Cr -4.05Cr -3.74Cr -7.09Cr -478.6Cr -49Cr -19Cr -234.21Cr -19Cr -18Cr -813.04Cr
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
09/26/09 A$2.880 +7.06% 18,87,525
08/26/08 A$2.690 -3.93% 9,26,765
07/26/07 A$2.800 -1.06% 1,66,873
06/26/06 A$2.830 +3.28% 3,75,953
03/26/03 A$2.740 +1.11% 1,46,950
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.690AUD
Average target price
3.540AUD
Spread / Average Target
+31.60%

Quarterly revenue - Rate of surprise